23andMe Independent Directors Quit Board Over Strategic Disagreements With CEO Anne Wojcicki

The independent directors of 23andMe announced their resignation from the board, citing dissatisfaction with CEO Anne Wojcicki's take-private offer. Wojcicki, who has been attempting to take the company private since April, proposed acquiring all outstanding shares not owned by her or her affiliates for USD 0.40 per share in July. In a letter to Wojcicki, the seven directors expressed frustration over not receiving a "fully financed, actionable proposal" in the best interests of non-affiliated shareholders. A special committee had previously rejected Wojcicki’s offer, calling it insufficient. The directors stated that no significant progress has been made over the last five months and that the board agrees with their decision. 23andMe went public in 2021. Data Breach: Biotech Firm 23andMe User Data Stolen in Credential-Stuffing Attack.

23andMe Independent Directors Resign

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)